Ohr Pharmaceutical, Inc 10-Q

Exhibit 32.1

 

Certification of Chief Executive Officer 

Pursuant to 18 U.S.C Section 1350, 

As Adopted Pursuant to Section 906 of the 

Sarbanes-Oxley Act of 2002

  

Not Filed Pursuant to the Securities Exchange Act of 1934

 

In connection with the Quarterly Report of Ohr Pharmaceutical, Inc. (the “Company” ) on Form 10-Q for the period ending June 30, 2013 as filed with the Securities and Exchange Commission on the date hereof the “Report” ), I, Irach Taraporewala , Chief Executive Officer, of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

  

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
     
  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

    

Dated: August 13, 2013  
   
/s/ Irach Taraporewala  
Name: Irach Taraporewala  
Title: Chief Executive Officer